← FDA Drug Approvals (Drugs@FDA)

VICTOZA

NDA · New Drug Application · Sponsor: NOVO NORDISK INC · Approved 2010-01-25

Drug application

FDA Application #

NDA022341

Application type

New Drug Application

Brand name

VICTOZA

Generic name

LIRAGLUTIDE

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVO NORDISK INC

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2010-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown